RED+BLUE STRATEGIES for EXPRESS SCRIPTS INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of the health reform law with a focus on regulations related to the medical loss ratio (MLR), Accountable Care Organizations, health transparency issues, e-prescribing and evolving the nation's health IT systems. Consolidated and Further Continuing Appropriations Act of 2015 (H.R. 83)- Issues related to Medicare and Medicaid prescription drug benefits. Issues related regulations that have the potential to the survey of mail order and specialty pharmacies for Medicaid purposes included in proposed OPM-focused policies in the Administration's 2015 Budget related to the utilization of Pharmacy Benefit Managers. Proposed regulations focused on Medicare Part C and D with a focus on provisions that would restructure the current part D program. Policies related to stopping prescription medication diversion. Issues related to international naming policies for biosimilar medications Issues related to mail order coverage for the Department of Defense. Issues related to Part D coverage for Medicare Beneficiaries in Hospice Care. Issues related to pricing of certain specialty medications.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Medicare/Medicaid MMM
Issues related regulations that have the potential to the survey of mail order and specialty pharmacies for Medicaid purposes included in proposed OPM-focused policies in the Administration's 2015 Budget related to the utilization of Pharmacy Benefit Managers. Proposed regulations focused on Medicare Part C and D with a focus on provisions that would restructure the current part D program. Policies related to stopping prescription medication diversion. Issues related to the Medicare Call Letter which could impact mail order utilization and access to preferred pharmacies in Medicare Part D ACA-related regulations impacting new rules for Exchanges specific to the promulgation of the prescription drug benefits. Issues related to Part D coverage for Medicare Beneficiaries in Hospice Care. Issues related to escalating costs of specialty medications and how they impact Medicare and Medicaid.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Pharmacy PHA
H.R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act - focused on policies that would negatively impact access to mail order pharmacy Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy. Issues impacting PBMs in up coming health related legislation. Policies related to stopping the diversion of prescription medications in the nation's drug supply chain. Changes in International Naming policies for generic medications. ACA-related regulations impacting new rules for Exchanges specific to the promulgation of the prescription drug benefits. Issues regarding prescription drug coverage for the Department of Defense. Issues related to Part D coverage for Medicare Beneficiaries in Hospice Care.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.